Urgent.News

600+ sources. One page. See who else covered it.

Editions

Science

Short-term risk of falls among initiators of controlled-release tapentadol versus oxycodone in New South Wales between 2014 and 2020: A population-based retrospective cohort study

by Ximena Camacho, Andrea L. Schaffer, Jonathan Brett, Ria Hopkins, Natasa Gisev, Steven Marsh, Kristian B. Filion, Nicole Pratt, David Henry, Sallie-Anne Pearson Background Clinical trials comparing sustained-release (SR) tapentadol with controlled-release (CR) oxycodone have suggested that tapentadol (SR) may be associated with fewer nervous system side effects. However, it remains important to…

We haven't written up this one. PLOS Medicine has the full story — the link below goes straight to it.

Read the original at journals.plos.org →

More in Science

More from Tuesday 11 August →